SEARCH

SEARCH BY CITATION

References

  • 1
    Theilmann L, Arnold J, Tox U et al. Liver transplantation and de novo hepatitis B infection. Lancet 1994; 343: 677678.
  • 2
    Douglas DD, Rakela J, Wright TL, Krom RA, Wiesner RH. The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient. Liver Transpl Surg 1997; 3: 105111.
    Direct Link:
  • 3
    Manzarbeitia C, Reich DJ, Ortiz JA, Rothstein KD, Araya VR, Munoz SJ. Safe use of livers from donors with positive hepatitis B core antibody. Liver Transpl 2002; 8: 556561.
  • 4
    Dickson RC, Everhart JE, Lake JR et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology 1997; 113: 16681674.
  • 5
    Prieto M, Gomez MD, Berenguer M et al. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transpl 2001; 7: 5158.
  • 6
    Roque-Afonso AM, Feray C, Samuel D et al. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors. Gut 2002; 50: 9599.
  • 7
    Sung JL. Hepatitis B virus infection and its sequelae in Taiwan. Gastroenterol Jpn 1984; 19: 363366.
  • 8
    Uemoto S, Sugiyama K, Marusawa H et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation 1998; 65: 494499.
  • 9
    Dodson SF, Bonham CA, Geller DA, Cacciarelli TV, Rakela J, Fung JJ. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. Transplantation 1999; 68: 10581061.
  • 10
    Yu AS, Vierling JM, Colquhoun SD et al. Transmission of hepatitis B infection from hepatitis B core antibody—positive liver allografts is prevented by lamivudine therapy. Liver Transpl 2001; 7: 513517.
  • 11
    Holt D, Thomas R, Van Thiel D, Brems JJ. Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation. Arch Surg 2002; 137: 572575; discussion 575–576.
  • 12
    Chen CL, Chen YS, De Villa VH et al. Minimal blood loss living donor hepatectomy. Transplantation 2000; 69: 25802586.
  • 13
    De Villa VH, Chen CL, Chen YS et al. Outflow tract reconstruction in living donor liver transplantation. Transplantation 2000; 70: 16041608.
  • 14
    Lin CC, Chuang FR, Wang CC et al. Early postoperative complications in recipients of living donor liver transplantation. Transplant Proc 2004; 36: 23382341.
  • 15
    Takatsuki M, Chen CL, Chen YS et al. Impact of late conversion from C0 to C2 monitoring of microemulsified cyclosporine in pediatric living donor liver transplant recipients. Clin Transplant 2004; 18: 694699.
  • 16
    Chang MH, Chen CJ, Lai MS et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997; 336: 18551859.
  • 17
    Ono Y, Onda H, Sasada R, Igarashi K, Sugino Y, Nishioka K. The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw. Nucleic Acids Res 1983; 11: 17471757.
  • 18
    De Villa VH, Chen YS, Chen CL. Hepatitis B core antibody-positive grafts: Recipient's risk. Transplantation 2003; 75(3 Suppl): S49S53.
  • 19
    Perrillo RP, Wright T, Rakela J et al. A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B. Hepatology 2001; 33: 424432.
  • 20
    Stark K, Gunther M, Schonfeld C, Tullius SG, Bienzle U. Immunisations in solid-organ transplant recipients. Lancet 2002; 359: 957965.
  • 21
    Castells L, Esteban R. Hepatitis B vaccination in liver transplant candidates. Eur J Gastroenterol Hepatol 2001; 13: 359361.
  • 22
    Duchini A, Goss JA, Karpen S, Pockros PJ. Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols. Clin Microbiol Rev 2003; 16: 357364.
  • 23
    Carman WF, Zanetti AR, Karayiannis P et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336: 325329.
  • 24
    Ghany MG, Ayola B, Villamil FG et al. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 1998; 27: 213222.
  • 25
    Tabor E. Infections by hepatitis B surface antigen gene mutants in Europe and North America. J Med Virol 2006; 78(Suppl 1): S43S47.